Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Cervical Cancer

  Free Subscription


18.06.2018

1 Acta Cytol
1 Am J Clin Oncol
2 Anticancer Res
1 Biomed Pharmacother
1 BMC Cancer
1 BMC Womens Health
1 Bull Cancer
1 Cell Cycle
1 Clin Med Insights Oncol
1 Eur J Clin Nutr
2 Gynecol Oncol Rep
1 Hum Gene Ther
3 Int J Oncol
1 Int J Radiat Oncol Biol Phys
2 J Clin Oncol
1 J Pak Med Assoc
1 J Transl Med
1 Med Sci Monit
1 Medicine (Baltimore)
1 Mol Cells
1 Oncol Rep
1 Orv Hetil
1 Pol J Pathol
1 Prev Med
1 Radiother Oncol
1 Sci Rep
1 Vaccine
1 Yonsei Med J
1 Zhonghua Bing Li Xue Za Zhi
6 Zhonghua Yu Fang Yi Xue Za Zhi


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Cytol

  1. MISRA JS, Srivastava AN, Gupta HP
    Results of Cervical Cancer Screening in the Rural Population of Lucknow West, India, through a Camp Approach.
    Acta Cytol. 2018 Jun 13:1-6. doi: 10.1159/000489078.
    PubMed     Text format     Abstract available


    Am J Clin Oncol

  2. AMINI A, Robin TP, Rusthoven CG, Schefter TE, et al
    Disparities Predict for Higher Rates of Cut-through Hysterectomies in Locally Advanced Cervical Cancer.
    Am J Clin Oncol. 2018 Jun 7. doi: 10.1097/COC.0000000000000473.
    PubMed     Text format     Abstract available


    Anticancer Res

  3. CHUNG T, DO SI, Na K, Kim G, et al
    Stromal p16 Overexpression in Gastric-type Mucinous Carcinoma of the Uterine Cervix.
    Anticancer Res. 2018;38:3551-3558.
    PubMed     Text format     Abstract available

  4. GADDUCCI A, Landoni F, Cosio S, Zizioli V, et al
    Neoadjuvant Platinum-based Chemotherapy Followed by Radical Hysterectomy for Stage Ib2-IIb Adenocarcinoma of the Uterine Cervix - An Italian Multicenter Retrospective Study.
    Anticancer Res. 2018;38:3627-3634.
    PubMed     Text format     Abstract available


    Biomed Pharmacother

  5. LU R, Yang Z, Xu G, Yu S, et al
    miR-338 modulates proliferation and autophagy by PI3K/AKT/mTOR signaling pathway in cervical cancer.
    Biomed Pharmacother. 2018;105:633-644.
    PubMed     Text format     Abstract available


    BMC Cancer

  6. GININDZA TG, Sartorius B
    Projected cervical Cancer incidence in Swaziland using three methods and local survey estimates.
    BMC Cancer. 2018;18:639.
    PubMed     Text format     Abstract available


    BMC Womens Health

  7. NEGA AD, Woldetsadik MA, Gelagay AA
    Low uptake of cervical cancer screening among HIV positive women in Gondar University referral hospital, Northwest Ethiopia: cross-sectional study design.
    BMC Womens Health. 2018;18:87.
    PubMed     Text format     Abstract available


    Bull Cancer

  8. PERNOT S, Pavie J, Pere H, Menard M, et al
    [Papillomavirus, could we speak about cancer and prevention?]
    Bull Cancer. 2018;105:137-139.
    PubMed     Text format    


    Cell Cycle

  9. QIU H, Li J, Liu Q, Tang M, et al
    Apatinib, a novel tyrosine kinase inhibitor, suppresses tumor growth in cervical cancer and synergizes with Paclitaxel.
    Cell Cycle. 2018 Jun 9. doi: 10.1080/15384101.2018.1471315.
    PubMed     Text format     Abstract available


    Clin Med Insights Oncol

  10. SKELTON WP 4TH, Castagno J, Cardenas-Goicoechea J, Daily K, et al
    Bevacizumab Eligibility in Patients with Metastatic and Recurrent Cervical Cancer: A Retrospective Review.
    Clin Med Insights Oncol. 2018;12:1179554918779587.
    PubMed     Text format     Abstract available


    Eur J Clin Nutr

  11. CARDOSO ICR, Aredes MA, Chaves GV
    Applicability of the direct parameters of bioelectrical impedance in assessing nutritional status and surgical complications of women with gynecological cancer.
    Eur J Clin Nutr. 2017 Aug 9. doi: 10.1038/ejcn.2017.
    PubMed     Text format     Abstract available


    Gynecol Oncol Rep

  12. SWANSON M, Ueda S, Chen LM, Huchko MJ, et al
    Evidence-based improvisation: Facing the challenges of cervical cancer care in Uganda.
    Gynecol Oncol Rep. 2018;24:30-35.
    PubMed     Text format     Abstract available

  13. NGOI NYL, Heong V, Lee XW, Huang YQ, et al
    Tumor molecular profiling of responders and non-responders following pembrolizumab monotherapy in chemotherapy resistant advanced cervical cancer.
    Gynecol Oncol Rep. 2018;24:1-5.
    PubMed     Text format     Abstract available


    Hum Gene Ther

  14. HOU W, Mao M, Shen Z, Chen Y, et al
    HOXD-AS1 exerts oncogenic functions and promotes chemoresistance in cisplatin-resistant cervical cancer cells.
    Hum Gene Ther. 2018 Jun 13. doi: 10.1089/hum.2017.
    PubMed     Text format     Abstract available


    Int J Oncol

  15. WANG Y, Yu X, Song H, Feng D, et al
    The STAT-ROS cycle extends IFNinduced cancer cell apoptosis.
    Int J Oncol. 2018;52:305-313.
    PubMed     Text format     Abstract available

  16. KANG MA, Kim W, Jo HR, Shin YJ, et al
    Anticancer and radiosensitizing effects of the cyclin-dependent kinase inhibitors, AT7519 and SNS032, on cervical cancer.
    Int J Oncol. 2018 May 31. doi: 10.3892/ijo.2018.4424.
    PubMed     Text format     Abstract available

  17. MUNGUIA-MORENO JA, Diaz-Chavez J, Garcia-Villa E, Albino-Sanchez ME, et al
    Early synergistic interactions between the HPV16E7 oncoprotein and 17beta-oestradiol for repressing the expression of Granzyme B in a cervical cancer model.
    Int J Oncol. 2018 Jun 6. doi: 10.3892/ijo.2018.4432.
    PubMed     Text format     Abstract available


    Int J Radiat Oncol Biol Phys

  18. LI R, Shinde A, Chen YJ, Amini A, et al
    Survival benefit of adjuvant brachytherapy after hysterectomy with positive surgical margins in cervical cancer.
    Int J Radiat Oncol Biol Phys. 2018 Jun 8. pii: S0360-3016(18)30929.
    PubMed     Text format     Abstract available


    J Clin Oncol

  19. GUPTA VG, Goel V
    Differences Between Chemotherapy-Resistant Disease and Inoperable Disease in Cervical Cancer Treated With Neoadjuvant Chemotherapy.
    J Clin Oncol. 2018 Jun 13:JCO2018786632. doi: 10.1200/JCO.2018.78.6632.
    PubMed     Text format    

  20. ZOU W, Hu C, Feng Y, Wang J, et al
    Treatment Protocols for Patients With Stage IB2, IIA, or IIB Squamous Cervical Cancer.
    J Clin Oncol. 2018 Jun 13:JCO2018788893. doi: 10.1200/JCO.2018.78.8893.
    PubMed     Text format    


    J Pak Med Assoc

  21. MEMON MM, Amin E
    Cervical cancer caused by human papillomavirus: Highly preventable yet highly under-diagnosed.
    J Pak Med Assoc. 2018;68:831.
    PubMed     Text format    


    J Transl Med

  22. DABI Y, Willecocq C, Ballester M, Carcopino X, et al
    Identification of a low risk population for parametrial invasion in patients with early-stage cervical cancer.
    J Transl Med. 2018;16:163.
    PubMed     Text format     Abstract available


    Med Sci Monit

  23. WANG L, Dai G, Yang J, Wu W, et al
    Cervical Cancer Cell Growth, Drug Resistance, and Epithelial-Mesenchymal Transition Are Suppressed by g-Secretase Inhibitor RO4929097.
    Med Sci Monit. 2018;24:4046-4053.
    PubMed     Text format     Abstract available


    Medicine (Baltimore)

  24. TAXIMAIMAITI R, Abudujilile D, Maihemuti M, Abuliken X, et al
    Expression of AMHR2 and C-KIT in cervical lesions in Uyghur Women of Xinjiang, China.
    Medicine (Baltimore). 2018;97:e10793.
    PubMed     Text format     Abstract available


    Mol Cells

  25. WANG CH, Shyu RY, Wu CC, Chen ML, et al
    Tazarotene-Induced Gene 1 Interacts with DNAJC8 and Regulates Glycolysis in Cervical Cancer Cells.
    Mol Cells. 2018 Jun 14. pii: molcells.2018.2347.
    PubMed     Text format     Abstract available


    Oncol Rep

  26. ZHAN Y, Zhang H, Dai B, Zhang Y, et al
    A novel biphenyl urea compound, TPD7, stimulates apoptosis through modulating Fas signaling and Bcl-2 family proteins in cervical cancer.
    Oncol Rep. 2018 Jun 4. doi: 10.3892/or.2018.6472.
    PubMed     Text format     Abstract available


    Orv Hetil

  27. KULLMANN T, Sipocz I, Agyemang-Prempeh K, Barna O, et al
    [Paclitaxel containing chemotherapeutic regimens in first line and reintroduced palliative treatment of metastatic cervical cancer].
    Orv Hetil. 2018;159:974-977.
    PubMed     Text format     Abstract available


    Pol J Pathol

  28. CELEWICZ A, Celewicz M, Wezowska M, Chudecka-Glaz A, et al
    Clinical efficacy of p16/Ki-67 dual-stained cervical cytology in secondary prevention of cervical cancer.
    Pol J Pathol. 2018;69:42-47.
    PubMed     Text format     Abstract available


    Prev Med

  29. FIRMINO-MACHADO J, Varela S, Mendes R, Moreira A, et al
    Stepwise strategy to improve cervical cancer screening adherence (SCAN-Cervical Cancer) - Automated text messages, phone calls and reminders: Population based randomized controlled trial.
    Prev Med. 2018 Jun 9. pii: S0091-7435(18)30194.
    PubMed     Text format    


    Radiother Oncol

  30. JENSEN NBK, Potter R, Kirchheiner K, Fokdal L, et al
    Bowel morbidity following radiochemotherapy and image-guided adaptive brachytherapy for cervical cancer: Physician- and patient reported outcome from the EMBRACE study.
    Radiother Oncol. 2018 Jun 4. pii: S0167-8140(18)30275.
    PubMed     Text format     Abstract available


    Sci Rep

  31. HWANG SH, Shin HY, Lee DO, Sung NY, et al
    A prospective pilot evaluation of vaginal and urine self-sampling for the Roche cobas 4800 HPV test for cervical cancer screening.
    Sci Rep. 2018;8:9015.
    PubMed     Text format     Abstract available


    Vaccine

  32. MCGREGOR S, Saulo D, Brotherton J, Liu B, et al
    Decline in prevalence of human papillomavirus infection following vaccination among Australian Indigenous women, a population at higher risk of cervical cancer: The VIP-I study.
    Vaccine. 2018 Jun 4. pii: S0264-410X(18)30771.
    PubMed     Text format     Abstract available


    Yonsei Med J

  33. KI EY, Lee YK, Lee A, Park JS, et al
    Comparison of the PANArray HPV Genotyping Chip Test with the Cobas 4800 HPV and Hybrid Capture 2 Tests for Detection of HPV in ASCUS Women.
    Yonsei Med J. 2018;59:662-668.
    PubMed     Text format     Abstract available


    Zhonghua Bing Li Xue Za Zhi

  34. FENG M, Zou J, Zhang Y, Sun L, et al
    [Neuroendocrine carcinoma of cervix: a clinicopathologic study of 82 cases].
    Zhonghua Bing Li Xue Za Zhi. 2018;47:328-333.
    PubMed     Text format     Abstract available


    Zhonghua Yu Fang Yi Xue Za Zhi

  35. HE ZH, Kou ZQ, Xu AQ
    [Human papillomavirus infection and vaccination].
    Zhonghua Yu Fang Yi Xue Za Zhi. 2018;52:106-112.
    PubMed     Text format     Abstract available

  36. ZHAO XL, Remila R, Hu SY, Zhang L, et al
    [Comparison of screening performance between primary high-risk HPV screening and high-risk HPV screening plus liquid-based cytology cotesting in diagnosis of cervical precancerous or cancerous lesions].
    Zhonghua Yu Fang Yi Xue Za Zhi. 2018;52:469-474.
    PubMed     Text format     Abstract available

  37. XU XQ, Zhang L, Hu SY, Rezhake R, et al
    [Role of HPV viral loads in random biopsy under normal colposcopy].
    Zhonghua Yu Fang Yi Xue Za Zhi. 2018;52:475-479.
    PubMed     Text format     Abstract available

  38. WANG YY, Lin W, Wu B, Yuan SX, et al
    [Distribution and associated factors of high-risk HPV genotypes infection among HPV-positive women who participated cervical screening test in Shenzhen, 2014-2016, China].
    Zhonghua Yu Fang Yi Xue Za Zhi. 2018;52:480-485.
    PubMed     Text format     Abstract available

  39. ZHAO S, Zhao FH
    [Research progress of HPV therapeutic vaccine].
    Zhonghua Yu Fang Yi Xue Za Zhi. 2018;52:556-560.
    PubMed     Text format     Abstract available

  40. HAN YF, Zhuang YN, Li Y, Fang Y, et al
    [Analysis of mothers' acceptance of HPV vaccination of adolescent girls in Xiamen].
    Zhonghua Yu Fang Yi Xue Za Zhi. 2018;52:38-42.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: